Christiaan de Wilde
Amministratore Delegato presso Fujirebio Europe NV
Profilo
Christiaan de Wilde is currently the Chief Executive Officer at Fujirebio Europe NV, and also holds the position of Co-Managing Director at Fujirebio Germany GmbH.
In the past, he worked as a Director at Janssen-Cilag International NV and as Director-Finance & Logistics at Johnson & Johnson Medical, Inc. from 2000 to 2005.
Posizioni attive di Christiaan de Wilde
| Società | Posizione | Inizio |
|---|---|---|
Fujirebio Europe NV
 Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | Amministratore Delegato | 01/01/2006 |
Fujirebio Germany GmbH
 Fujirebio Germany GmbH Pharmaceuticals: MajorHealth Technology Part of H.U. Group Holdings, Inc., Fujirebio Germany GmbH develops and manufactures pharmaceutical products. The company is based in Hannover, Germany. The CEO of the company is Christiaan de Wilde. | Amministratore Delegato | - |
Precedenti posizioni note di Christiaan de Wilde
| Società | Posizione | Fine |
|---|---|---|
Johnson & Johnson Medical, Inc.
 Johnson & Johnson Medical, Inc. Medical SpecialtiesHealth Technology Part of Johnson & Johnson, Johnson & Johnson Medical, Inc. is a company that manufactures surgical appliances. The company is based in Arlington, TX. | Direttore Finanziario/CFO | 01/05/2005 |
Janssen-Cilag International NV
 Janssen-Cilag International NV BiotechnologyHealth Technology Part of Johnson & Johnson, Janssen-Cilag International NV is a Belgian company that develops novel medicines and solutions. Bart Willem van Zijll Langhout has been the CEO of the company since 2009. | Direttore/Membro del Consiglio | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Janssen-Cilag International NV
Janssen-Cilag International NV BiotechnologyHealth Technology Part of Johnson & Johnson, Janssen-Cilag International NV is a Belgian company that develops novel medicines and solutions. Bart Willem van Zijll Langhout has been the CEO of the company since 2009. | Health Technology |
Fujirebio Europe NV
Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | Health Technology |
Johnson & Johnson Medical, Inc.
Johnson & Johnson Medical, Inc. Medical SpecialtiesHealth Technology Part of Johnson & Johnson, Johnson & Johnson Medical, Inc. is a company that manufactures surgical appliances. The company is based in Arlington, TX. | Health Technology |
Fujirebio Germany GmbH
Fujirebio Germany GmbH Pharmaceuticals: MajorHealth Technology Part of H.U. Group Holdings, Inc., Fujirebio Germany GmbH develops and manufactures pharmaceutical products. The company is based in Hannover, Germany. The CEO of the company is Christiaan de Wilde. | Health Technology |
- Borsa valori
- Insiders
- Christiaan de Wilde
